Jeffrey Henley - 12 Mar 2024 Form 4 Insider Report for ORACLE CORP (ORCL)

Role
Vice Chairman, Director
Signature
/s/ Aimee Weast By Aimee Weast, Attorney in Fact for Jeffrey Henley (POA Filed 03/20/19)
Issuer symbol
ORCL
Transactions as of
12 Mar 2024
Net transactions value
-$34,580,082
Form type
4
Filing time
14 Mar 2024, 16:31:54 UTC
Previous filing
21 Dec 2023
Next filing
07 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORCL Common Stock Options Exercise $16,188,000 +400,000 +36% $40.47 1,507,916 12 Mar 2024 by Trust
transaction ORCL Common Stock Sale $7,637,635 -60,978 -4% $125.25 1,446,938 12 Mar 2024 by Trust F1, F2
transaction ORCL Common Stock Sale $15,980,236 -126,567 -8.7% $126.26 1,320,371 12 Mar 2024 by Trust F1, F3
transaction ORCL Common Stock Sale $13,554,284 -106,654 -8.1% $127.09 1,213,717 12 Mar 2024 by Trust F1, F4
transaction ORCL Common Stock Sale $10,203,284 -79,507 -6.6% $128.33 1,134,210 12 Mar 2024 by Trust F1, F5
transaction ORCL Common Stock Sale $3,392,644 -26,294 -2.3% $129.03 1,107,916 12 Mar 2024 by Trust F1, F6
holding ORCL Common Stock 706,214 12 Mar 2024 By GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORCL Stock Option Options Exercise $0 -400,000 -100% $0.000000* 0 12 Mar 2024 Common Stock 400,000 $40.47 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale of shares pursuant to Rule 10b5-1 Plan adopted on October 9, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $124.75. to $125.74. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $125.76. to $126.72. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $126.78. to $127.74. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $127.81. to $128.77. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $128.83. to $129.37. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 25% of the shares subject to the option vested annually on each anniversary of the grant date.